<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2021.12273</article-id>
<article-id pub-id-type="publisher-id">MMR-0-0-12273</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sirt3 promotes the autophagy of HK-2 human proximal tubular epithelial cells via the inhibition of Notch-1/Hes-1 signaling</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Ying</given-names></name>
<xref rid="af1-mmr-0-0-12273" ref-type="aff">1</xref>
<xref rid="af2-mmr-0-0-12273" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Chang</surname><given-names>Jiang</given-names></name>
<xref rid="af3-mmr-0-0-12273" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Zi-Qiang</given-names></name>
<xref rid="af2-mmr-0-0-12273" ref-type="aff">2</xref>
<xref rid="af4-mmr-0-0-12273" ref-type="aff">4</xref></contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Ying</given-names></name>
<xref rid="af2-mmr-0-0-12273" ref-type="aff">2</xref>
<xref rid="c1-mmr-0-0-12273" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-mmr-0-0-12273"><label>1</label>Department of Nephrology, Bayan Nur Hospital, Bayan Nur, Inner Mongolia Autonomous Region 015000, P.R. China</aff>
<aff id="af2-mmr-0-0-12273"><label>2</label>Department of Nephrology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China</aff>
<aff id="af3-mmr-0-0-12273"><label>3</label>Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Hainan Medical College, Haikou, Hainan 570102, P.R. China</aff>
<aff id="af4-mmr-0-0-12273"><label>4</label>Department of Blood Purification, The First Affiliated Hospital of Hainan Medical College, Haikou, Hainan 570102, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-0-0-12273"><italic>Correspondence to</italic>: Dr Ying Li, Department of Nephrology, The Third Hospital of Hebei Medical University, 139 Ziqiang Road, Shijiazhuang, Hebei 050051, P.R. China, E-mail: <email>yingliihebei@163.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>09</month>
<year>2021</year></pub-date>
<pub-date pub-type="epub">
<day>06</day>
<month>07</month>
<year>2021</year></pub-date>
<volume>24</volume>
<issue>3</issue>
<elocation-id>634</elocation-id>
<history>
<date date-type="received"><day>23</day><month>02</month><year>2021</year></date>
<date date-type="accepted"><day>11</day><month>06</month><year>2021</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Wang et al.</copyright-statement>
<copyright-year>2021</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>Diabetic nephropathy (DN) is a predominant cause of end-stage renal disease. The impairment of the autophagy of human renal tubular epithelial cells (HK-2 cells) is involved in the pathogenic mechanisms of DN. Sirtuin (Sirt)3 regulates the scavenging of damaged organelles and maintains energy balance. The present study aimed to examine the protective effects of Sirt3 on HK-2 cells stimulated by high glucose (HG). HK-2 cells were cultured in normal glucose (NG), HG or hyperosmotic medium. The viability of the HK-2 cells was detected using a Cell Counting Kit-8 assay. The expression and localization of Sirt3 were detected via immunofluorescence. Following transfection with an overexpression plasmid, the expression levels of key components in the Notch homolog 1 (Notch-1)/hairy and enhancer of split-1 (Hes-1) pathway and those of the autophagy-related proteins, Beclin-1, LC-3II and p62, were measured by western blot analysis and reverse transcription-quantitative PCR (RT-qPCR). As the Notch-1/Hes-1 pathway was inhibited, the expression levels of Beclin-1, LC-3II and p62 were also examined at transcriptional and translational level. It was found that prolonged culture in HG medium markedly reduced cell viability compared with the cells cultured in NG or in NG &#x002B; mannitol, an effect that was aggravated with the increasing duration of culture. HG was capable of inhibiting the expression levels of Beclin-1, LC-3II and Sirt3, and upregulating p62 and the Notch-1/Hes-1 pathway, as verified by western blot analysis and RT-qPCR. The results of immunofluorescence staining revealed that HG decreased Sirt3 expression. Sirt3 reversed the HG-induced inhibition of the expression of Beclin-1 and LC-3II and the upregulation of p62. Moreover, Sirt3 reversed the HG-induced inhibition of the Notch-1/Hes-1 signaling pathway. However, this autophagy-promoting effect of Sirt3 was counteracted by the Notch-1/Hes-1 pathway activator. On the whole, the present study demonstrated that Sirt3 promoted the autophagy of HK-2 cells, at least partly, via the downregulation of Notch-1/Hes-1.</p>
</abstract>
<kwd-group>
<kwd>glucose</kwd>
<kwd>autophagy</kwd>
<kwd>Sirtuin 3</kwd>
<kwd>Notch homolog 1</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Natural Science Fund of Inner Mongolia Autonomous Region</funding-source>
<award-id>2019MS08064</award-id>
</award-group>
<funding-statement>This study was supported by the Natural Science Fund of Inner Mongolia Autonomous Region (grant no. 2019MS08064).</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>As one of the severe microvascular complications of type 2 diabetes mellitus, diabetic nephropathy (DN) is the leading cause of end-stage renal disease (<xref rid="b1-mmr-0-0-12273" ref-type="bibr">1</xref>). Although diagnosis and treatment technologies have improved, the incidence of DN is increasing worldwide (<xref rid="b2-mmr-0-0-12273" ref-type="bibr">2</xref>). Therefore, there is an urgent need to clarify the molecular pathogenesis of DN and to identify therapeutic targets.</p>
<p>Autophagic dysfunction is considered to be involved in DN (<xref rid="b3-mmr-0-0-12273" ref-type="bibr">3</xref>). Autophagy is a cellular recycling pathway that is essential for maintaining cellular integrity (<xref rid="b3-mmr-0-0-12273" ref-type="bibr">3</xref>). Under stress conditions, human proximal tubular epithelial (HK-2) cells exploit the autophagic machinery to clear damaged organelles and protein aggregates. The degradation and recycling process of autophagy contributes to maintaining normal cellular functions and delays the progression of diabetic renal injury (<xref rid="b4-mmr-0-0-12273" ref-type="bibr">4</xref>). Previous research has demonstrated that during autophagy, lysosomes contribute to the regulation of the degradation of damaged cellular components as an adaptive response, playing an important role in the pathogenesis of DN (<xref rid="b3-mmr-0-0-12273" ref-type="bibr">3</xref>,<xref rid="b5-mmr-0-0-12273" ref-type="bibr">5</xref>). As a result, the high glucose (HG)-induced impairment of autophagy in renal tubular epithelial cells has emerged as an important process responsible for the occurrence and development of diabetic renal injury.</p>
<p>Multiple regulatory mechanisms modulate autophagy in DN, including nutrient signaling pathways (<xref rid="b6-mmr-0-0-12273" ref-type="bibr">6</xref>). Among these, Sirtuin (Sirt)1 functions as an important regulator of autophagy (<xref rid="b7-mmr-0-0-12273" ref-type="bibr">7</xref>). As a member of the Sirt family, Sirt1 has been reported to contribute to the clearance of damaged organelles and the maintenance of energy homeostasis (<xref rid="b8-mmr-0-0-12273" ref-type="bibr">8</xref>). Sirt3 belongs to the same family as Sirt1, and is capable of regulating signaling pathways when stress occurs, thereby inducing autophagy (<xref rid="b9-mmr-0-0-12273" ref-type="bibr">9</xref>,<xref rid="b10-mmr-0-0-12273" ref-type="bibr">10</xref>). In a previous study, in a model of sepsis-induced acute kidney injury, Sirt3 was demonstrated to promote autophagy, alleviating acute kidney injury, tubular cell apoptosis and inflammatory responses in the kidneys (<xref rid="b11-mmr-0-0-12273" ref-type="bibr">11</xref>). Moreover, through the activation of the process of autophagy, Sirt3 significantly attenuates the occurrence and development of diabetes-related microvascular complications (<xref rid="b12-mmr-0-0-12273" ref-type="bibr">12</xref>). Sirt3 has also been shown to inhibit mitochondrial injury and cardiomyocyte apoptosis through the activation of autophagy and mitophagy in HG-stimulated cardiomyocytes (<xref rid="b13-mmr-0-0-12273" ref-type="bibr">13</xref>). Mesenchymal stem cells have been shown to attenuate diabetic lung fibrosis by modulating Sirt3-mediated stress responses, such as the enhancement of autophagy and inhibition of oxidative stress, inflammation, apoptosis and endoplasmic reticulum stress (<xref rid="b14-mmr-0-0-12273" ref-type="bibr">14</xref>).</p>
<p>With regards to the pathways regulating autophagy, Notch homolog 1 (Notch-1)/hairy and enhancer of split-1 (Hes-1) has been proven to be involved in cell proliferation, differentiation and death (<xref rid="b15-mmr-0-0-12273" ref-type="bibr">15</xref>). Moreover, this pathway has been shown to regulate the equilibrium between autophagosome formation and clearance by lysosomes in podocytes (<xref rid="b16-mmr-0-0-12273" ref-type="bibr">16</xref>). However, whether this pathway plays a role in the autophagic process in renal tubular epithelial cells is not yet fully understood, and the function of Sirt3 in modulating autophagy in HG-stimulated proximal tubular epithelial cell injury remains undetermined. Thus, the present study aimed to evaluate the renoprotective effects of Sirt3 against DN. Additionally, whether Sirt3 overexpression attenuates kidney injury via modulating autophagy in HG-stimulated proximal tubular epithelial cells was determined.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Cell culture and treatment</title>
<p>HK-2 cells were purchased from the American Type Culture Collection and cultured as previously described (<xref rid="b17-mmr-0-0-12273" ref-type="bibr">17</xref>). All cells were cultured in DMEM (Invitrogen; Thermo Fisher Scientific, Inc.) with 10&#x0025; FBS (HyClone; Cygtiva) at 37&#x00B0;C, 5&#x0025; CO<sub>2</sub> in a humidified incubator. Cells (5&#x00D7;10<sup>5</sup> cells/well) were seeded in 6-well plates at 80&#x0025; confluency and continued to be cultured in DMEM with 2&#x0025; FBS. The HK-2 cells were serum-starved for 24 h, followed by exposure to DMEM with 5.5 mM glucose [normal glucose (NG)], 30 mM glucose (HG) or NG &#x002B; hyperosmotic medium [24.5 mmol/l mannitol (M)]. Following washing three times with 1X PBS, the HK-2 cells were harvested for the cell viability assay. This was followed by transfection with overexpression plasmid and the inhibition of the Notch-1/Hes-1 pathway.</p>
</sec>
<sec>
<title>Cell viability assay</title>
<p>HK-2 cells were cultured in the designated medium for an additional 6, 12, 24, 48 and 72 h. Cell viability was determined using a Cell Counting Kit-8 (CCK-8; MedChemExpress) assay. Briefly, the HK-2 cells were washed and plated at a density of 1&#x00D7;10<sup>3</sup>&#x2212;10<sup>4</sup> cells per well in a 96-well plate. Cells were incubated in fresh medium at 37&#x00B0;C for an additional 48 h. Subsequently, CCK-8 solution (10 &#x00B5;l) was added to each well of the culture medium at each time point, according to the manufacturer&#x0027;s instructions. The plates were kept at 37&#x00B0;C with 5&#x0025; CO<sub>2</sub> in an incubated plate holder for 1 h. The absorbance was determined using a microplate reader (BioTek microplate reader; BioTek Instruments, Inc.) at 450 nm.</p>
</sec>
<sec>
<title>Transfection with overexpression plasmid</title>
<p>HK-2 cells were seeded in a 6-well plate at a density of 5&#x00D7;10<sup>5</sup> cells/well for 48 h. Plasmid transfection was performed using FuGENE 6 (Promega Corporation) according to the manufacturer&#x0027;s instructions. The plasmids used in the present study were described previously and confirmed by DNA sequencing (<xref rid="b18-mmr-0-0-12273" ref-type="bibr">18</xref>). Cells were transfected with 2 &#x00B5;g pCMV-SIRT3 or empty pCMV-vector (Integrated Biotech Solutions) at 37&#x00B0;C. Following 48 h of transfection, the HK-2 cells were stimulated with HG for 48 h at 37&#x00B0;C. The transfection efficacy was determined by reverse transcription-quantitative PCR (RT-qPCR) and western blot analysis.</p>
</sec>
<sec>
<title>Inhibition of the Notch-1/Hes-1 pathway</title>
<p>To activate the Notch-1/Hes-1 pathway, Jagged1-FC (final concentration, 0.5 &#x00B5;g/ml; cat. no. 1277-JG; R&#x0026;D Systems, Inc.) was added to the medium and the incubation was continued for a further 2 h at room temperature.</p>
</sec>
<sec>
<title>Western blot analysis</title>
<p>Western blot analysis was performed as previously described (<xref rid="b19-mmr-0-0-12273" ref-type="bibr">19</xref>). The HK-2 cells were washed with 1X PBS three times and lysed with RIPA lysis buffer (Beyotime Institute of Biotechnology). Total protein extracts were collected and the concentration was quantified using a BCA assay (Pierce; Thermo Fisher Scientific, Inc.). Total protein (30 &#x00B5;g) was loaded onto 10&#x0025; SDS-PAGE (Beijing Solarbio Science &#x0026; Technology Co., Ltd.) followed by transfer onto PVDF membranes (Bio-Rad Laboratories, Inc.). The membranes were blocked with TBS containing 0.1&#x0025; Tween-20 (TBST) containing 5&#x0025; non-fat milk for 1 h at room temperature, followed by primary antibody incubation overnight at 4&#x00B0;C. The antibodies were as follows: Anti-Beclin-1 (cat. no. ab210498; 1:1,000; Abcam), anti-LC-3II (cat. no. ab48394; 1:1,000; Abcam), anti-p62 (cat. no. ab56416; 1:1,000; Abcam), anti-Sirt3 (cat. no. ab217319; 1:1,000; Abcam), anti-Notch-1 (cat. no. ab52627; 1:1,000; Abcam), anti-Hes-1 (cat. no. ab108937; 1:1,000; Abcam) and anti-&#x03B2;-actin (cat. no. ab8227; 1:1,000; Abcam). Following washing with TBST three times for 15 min, the membranes were then incubated with HRP-conjugated secondary antibodies (cat. no. 7074 and 7076; 1:1,000; Cell Signaling Technology, Inc.) for 2 h at room temperature. Proteins were visualized using the ECL method (Thermo Fisher Scientific, Inc.). Semi-quantification of the western blot bands was performed using ImageJ software (version 1.8.0; National Institutes of Health).</p>
</sec>
<sec>
<title>RT-qPCR analysis</title>
<p>Total cellular mRNA of Beclin-1, LC-3II, p62, Sirt3, Notch-1 and Hes-1 was isolated using TRIzol<sup>&#x00AE;</sup> reagent (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer&#x0027;s instructions. RT-qPCR was performed as previously described (<xref rid="b15-mmr-0-0-12273" ref-type="bibr">15</xref>). Total RNA (2 &#x00B5;g) extracted from the cultured cells was used as a template for cDNA synthesis. The primer sequences were as follows: Beclin-1 forward, 5&#x2032;-AATGACTTTTTTCCTTAGGGGG-3&#x2032; and reverse, 5&#x2032;-GTGGCTTTTGTGGATTTTTTCT-3&#x2032;; LC-3II forward, 5&#x2032;-AGTGCCTGTGTTGTTACGGA-3&#x2032; and reverse, 5&#x2032;-GCAGAAGGGAGTGTGTCTGA-3&#x2032;; p62 forward, 5&#x2032;-AGTCGGAGCGGGTTCTCTAT-3&#x2032; and reverse, 5&#x2032;-GTGACACACATTCCAGCGAT-3&#x2032;; Notch-1 forward, 5&#x2032;-CAGACAGGCAGGTGGGGTCGTGGTA-3&#x2032; and reverse, 5&#x2032;-GCGACAACGCCTACCTCTG-3&#x2032;; Hes-1 forward, 5&#x2032;-CAACACGACACCGGATAAAC-3&#x2032; and reverse, 5&#x2032;-TTCAGCTGGCTCAGACTTTC-3&#x2032;; and &#x03B2;-actin forward, 5&#x2032;-TGACGTGGACATCCGCAAAG-3&#x2032; and reverse, 5&#x2032;-CTGGAAGGTGGACAGCGAGG-3&#x2032;. The conditions for amplification were as follows: Initial denaturation at 95&#x00B0;C for 5 min, followed by 40 cycles each at 95&#x00B0;C for 10 sec, followed by 60&#x00B0;C for 30 sec, and 72&#x00B0;C for 45 sec. &#x03B2;-actin mRNA served as an endogenous control. The relative quantities of products were determined using the 2<sup>&#x2212;&#x0394;&#x0394;Cq</sup> method (<xref rid="b20-mmr-0-0-12273" ref-type="bibr">20</xref>). The experiments were performed in triplicate for each group.</p>
</sec>
<sec>
<title>Cell immunofluorescence</title>
<p>Following seeding on coverslips in 6-well plates (2&#x00D7;10<sup>5</sup> cells/well), the cells were fixed with 4&#x0025; paraformaldehyde for 10 min at 4&#x00B0;C. Subsequently, the cells were blocked with 10&#x0025; goat serum (Beijing Solarbio Science &#x0026; Technology Co., Ltd.) for 15 min at room temperature, and subjected to immunofluorescence staining with anti-Sirt3 polyclonal antibody (1:500; cat. no. ab40963; Abcam) as the primary antibody. Following incubation overnight with anti-Sirt3 antibody at 4&#x00B0;C, the HK-2 cells were then incubated with Cy3-labeled IgG (cat. no. TA130020; 1:100; OriGene Technologies, Inc.) for 1 h at room temperature. The following day, the nuclei were stained with DAPI for 10 min at room temperature. Immunofluorescence was observed and captured using a fluorescence microscope (Olympus Corporation).</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>All experiments were carried out in triplicate. The analyses were performed using SPSS software (version 23.0; IBM Corp.). Data are expressed as the mean &#x00B1; SD. For multiple comparisons between groups, a one-way ANOVA followed by Tukey&#x0027;s post hoc test was performed. P&#x003C;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>HG reduces the viability of HK-2 cells</title>
<p>HK-2 cell cultivation was performed in NG, HG or a hyperosmotic environment, and cell viability was then determined using a CCK-8 assay (<xref rid="f1-mmr-0-0-12273" ref-type="fig">Fig. 1</xref>). When the HK-2 cells were incubated in HG culture medium for 6 and 12 h, it was observed that there was a slight increase in cell viability compared with cells cultivated in NG. However, treatment with NG &#x002B; M decreased cell viability compared with the NG group over the culturing time. Of note, HG markedly decreased cell viability compared with the cells treated with NG and NG &#x002B; M with the duration of culture.</p>
</sec>
<sec>
<title>Long-term culture of HK-2 cells in HG inhibits the expression of Sirt3 and autophagy</title>
<p>After the cells were subjected to the different treatments (NG, NG &#x002B; M and HG), the expression level of Sirt3 was detected (<xref rid="f2-mmr-0-0-12273" ref-type="fig">Fig. 2A</xref>). The expression of Sirt3 exhibited an unremarkable change in the HK-2 cells cultured in NG &#x002B; M compared with the NG group. Compared with the NG group, the protein expression level of Sirt3 was significantly decreased in the HK-2 cells following stimulation with HG for 48 h (<xref rid="f2-mmr-0-0-12273" ref-type="fig">Fig. 2B</xref>). A similar trend was observed in the cell immunofluorescence assay (<xref rid="f2-mmr-0-0-12273" ref-type="fig">Fig. 2J</xref>). Short-term HG culture (6 and 12 h) led to a significant elevation in Sirt3 protein expression. However, the expression level of Sirt3 tended to decrease with the increasing incubation time. No further changes in Sirt3 protein expression were observed at 48 h. Sirt3 mRNA expression exhibited a similar trend with that of its protein expression determined by western blot analysis (<xref rid="f2-mmr-0-0-12273" ref-type="fig">Fig. 2C</xref>).</p>
<p>In order to evaluate the effects of HG on autophagic activation in HK-2 cells, western blot analysis and RT-qPCR were performed to determine the mRNA and protein expression levels of Beclin-1, LC-3II and p62 (<xref rid="f2-mmr-0-0-12273" ref-type="fig">Fig. 2A and D-I</xref>). HG increased the protein expression levels of Beclin-1 and LC-3II at 6 and 12 h compared with the NG group. However, at later time points, HG significantly decreased Beclin-1 and LC-3II protein expression levels. These levels exhibited a downward trend from 24 h, with the most significant decrease observed at 48 h (<xref rid="f2-mmr-0-0-12273" ref-type="fig">Fig. 2D and F</xref>). With regards to p62 expression, the opposite trend was observed (<xref rid="f2-mmr-0-0-12273" ref-type="fig">Fig. 2H</xref>). Similar results were obtained by RT-qPCR (<xref rid="f2-mmr-0-0-12273" ref-type="fig">Fig. 2E, G and I</xref>).</p>
</sec>
<sec>
<title>Long-term culture of HK-2 cells in HG activates Notch-1/Hes-1 signaling</title>
<p>The expression levels of key proteins in the Notch-1/Hes-1 pathway were moderately expressed in the HK-2 cells (<xref rid="f3-mmr-0-0-12273" ref-type="fig">Fig. 3A</xref>). At 48 h, there was significant activation of the Notch-1/Hes-1 pathway in the HK-2 cells cultured in NG &#x002B; M compared with the NG group. Following a phase of inhibition, the Notch-1/Hes-1 pathway was significantly activated in the cells stimulated with HG for 48 h (<xref rid="f3-mmr-0-0-12273" ref-type="fig">Fig. 3B and D</xref>). Similar to the results obtained by western blot analysis, HG upregulated the expression of Notch-1/Hes-1 at the transcriptional level at 48 h (<xref rid="f3-mmr-0-0-12273" ref-type="fig">Fig. 3C and E</xref>).</p>
</sec>
<sec>
<title>Sirt3 activates autophagy in HG-stimulated HK-2 cells</title>
<p>As shown in <xref rid="f4-mmr-0-0-12273" ref-type="fig">Fig. 4D-J</xref>, HG significantly decreased Beclin-1 and LC-3II expression, whereas it significantly increased p62 expression compared with the HK-2 cells in the NG group. Following transfection with pCMV-Sirt3, Sirt3 was significantly upregulated compared with the control-vector group (<xref rid="f4-mmr-0-0-12273" ref-type="fig">Fig. 4A and B</xref>), and Sirt3 was effectively activated when treated with HG &#x002B; pCMV-Sirt3 compared with the HG &#x002B; pCMV-vector group (<xref rid="f4-mmr-0-0-12273" ref-type="fig">Fig. 4D</xref>). Compared with NG and HG group, the overexpression of Sirt3 by transfection with pCMV-Sirt3 significantly enhanced cell viability at 48 h in the NG &#x002B; pCMV-vector and HG &#x002B; pCMV-vector groups, respectively (<xref rid="f4-mmr-0-0-12273" ref-type="fig">Fig. 4C</xref>). In addition, the expression of Beclin-1 and LC-3II was significantly elevated at the transcriptional and translational levels in the HG &#x002B; pCMV-Sirt3 group compared with the HG group. Moreover, pCMV-Sirt3 significantly decreased p62 expression compared with the HG group (<xref rid="f4-mmr-0-0-12273" ref-type="fig">Fig. 4E-J</xref>). These results demonstrated that Sirt3 reversed the inhibition of autophagy induced by HG. Moreover, the results presented in <xref rid="f4-mmr-0-0-12273" ref-type="fig">Fig. 4K and L</xref> also demonstrated that HG inhibited the expression of Sirt3 at the transcriptional level compared with the NG group.</p>
</sec>
<sec>
<title>Sirt3 inhibits the Notch-1/Hes-1 pathway in HG-stimulated HK-2 cells</title>
<p>The expression of Notch-1 (<xref rid="f5-mmr-0-0-12273" ref-type="fig">Fig. 5A-C</xref>) and Hes-1 (<xref rid="f5-mmr-0-0-12273" ref-type="fig">Fig. 5A, D and E</xref>) was significantly elevated in the HK-2 cells following stimulation with HG for 48 h compared with the NG group. Nevertheless, the HG-induced activation of the Notch-1/Hes-1 pathway was attenuated when the cells were transfected with pCMV-Sirt3, which suggested that Sirt3 inhibited the Notch-1/Hes-1 pathway in the HG-stimulated HK-2 cells.</p>
</sec>
<sec>
<title>Sirt3 upregulates autophagy in HK-2 cells via the inhibition of Notch-1/Hes-1 signaling</title>
<p>As illustrated in <xref rid="f6-mmr-0-0-12273" ref-type="fig">Fig. 6A-E</xref>, HG could induce activation of the Notch-1/Hes-1 signaling pathway, which was inhibited by Sirt3. Notch-1/Hes-1 pathway activation via the Notch-1/Hes-1 pathway activator, Jagged-1, significantly upregulated Notch-1/Hes-1 protein expression compared with the HG &#x002B; pCMV-Sirt3 group. As shown in <xref rid="f6-mmr-0-0-12273" ref-type="fig">Fig. 6F</xref>, a marked decrease in Beclin-1 and LC-3II expression was observed in the HK-2 cells following stimulation with HG for 48 h (<xref rid="f6-mmr-0-0-12273" ref-type="fig">Fig. 6G-J</xref>). The accumulation of p62 was also detected in the HG-stimulated cells (<xref rid="f6-mmr-0-0-12273" ref-type="fig">Fig. 6K and L</xref>). However, the autophagic process was activated when the cells were treated with HG &#x002B; pCMV-Sirt3. A significant decrease in Beclin-1 and LC-3II, and a pronounced rise in P62 was detected in the HG &#x002B; pCMV-Sirt3 &#x002B; Jagged-1 group compared with the HG &#x002B; pCMV-Sirt3 group (<xref rid="f6-mmr-0-0-12273" ref-type="fig">Fig. 6G-L</xref>). These results indicated that Sirt3 positively regulated autophagy via the inhibition of the Notch-1/Hes-1 pathway.</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>Autophagy is a basic process of physiological metabolism that functions to remove impaired organelles and protein aggregates, resulting in the recycling and remobilization of nutrients (<xref rid="b21-mmr-0-0-12273" ref-type="bibr">21</xref>). The dysfunction of the process of autophagy has been reported to be an important pathogenic mechanism and it plays a role in the occurrence and development of several diseases (<xref rid="b22-mmr-0-0-12273" ref-type="bibr">22</xref>). Under HG stress conditions, the impairment of autophagy predisposes nephrocytes to accumulate unfolded proteins and damaged organelles (<xref rid="b23-mmr-0-0-12273" ref-type="bibr">23</xref>). The inhibition of autophagy induced by HG is considered to be one of the key pathogenetic factors for DN (<xref rid="b24-mmr-0-0-12273" ref-type="bibr">24</xref>). Studies have suggested that the alleviation of autophagic obstruction is involved in the repair of the damage caused to renal tubular epithelial cells by hyperglycemia (<xref rid="b25-mmr-0-0-12273" ref-type="bibr">25</xref>,<xref rid="b26-mmr-0-0-12273" ref-type="bibr">26</xref>). Although there is evidence that focused on the autophagic process in DN, the molecular mechanisms responsible for the regulation of autophagy remain unclear.</p>
<p>In the present study, it was found that cell viability increased during the early phase of HG stimulation. The viability of the HK-2 cells was decreased by extending the incubation time. In parallel, autophagy was suppressed in the HK-2 cells. The inhibitory effect was most evident at 48 h and later time points. A number of theoretical hypotheses have been proposed to explain the molecular pathways regulating autophagy in the diabetes-induced damage to renal tubular epithelial cells (<xref rid="b24-mmr-0-0-12273" ref-type="bibr">24</xref>). Among these, Sirt1, which has been implicated as a nicotinamide adenine dinucleotide-dependent deacetylase, has been reported to be a positive regulator of autophagy (<xref rid="b27-mmr-0-0-12273" ref-type="bibr">27</xref>). Sirt1 serves as a potential renoprotective factor. The low expression of Sirt1 has been shown to lead to diabetic renal injury via the negative regulation of autophagy (<xref rid="b24-mmr-0-0-12273" ref-type="bibr">24</xref>). Sirt1 and Sirt3 belong to the same family and can both mediate the regulation of autophagy. In the present study, HG decreased Sirt3 expression in the HK-2 cells. To date, at least to the best of our knowledge, there is no in-depth study available on the effects of HG on Sirt3. The mechanisms through which Sirt3 functions in response to environmental signals remain to be determined. Previously, in animal experiments, Sirt3 was shown to ameliorate autophagy dysfunction in acute tubular cell injury, resulting in the upregulation of LC-3II and Beclin-1 expression (<xref rid="b11-mmr-0-0-12273" ref-type="bibr">11</xref>). Additionally, a previous <italic>in vitro</italic> study revealed that Sirt3 attenuated the inhibition of autophagy induced by high levels of oxalic acid in renal tubular epithelial cells; this led to the suppression of cell apoptosis and necrosis, as well as in the protection of renal function (<xref rid="b28-mmr-0-0-12273" ref-type="bibr">28</xref>). In the present study, Sirt3 activated autophagy in the HG-stimulated HK-2 cells, as evidenced by the upregulation of LC-3II and Beclin-1, and the downregulation of p62 expression, either at the transcriptional or post-transcriptional levels in the HK-2 cells. These results are in accordance with those of a similar previous study (<xref rid="b11-mmr-0-0-12273" ref-type="bibr">11</xref>). However, unlike the present study, the previous study focused on renal tubular cell damage caused by sepsis rather than HG-induced renal tubular cell damage. Due to the different pathogenic mechanisms, whether the two diseases have anything in common in regulatory pathways warrants further investigation.</p>
<p>With regards to the exact mechanisms through which Sirt3 promoted autophagy, it has previously been reported that Sirt3 regulates the autophagic process by activating different downstream signaling pathways. Previously, in a cell model of rotenone-induced Parkinson&#x0027;s disease, Sirt3 was found to protect against neurodegenerative disease through the regulation of autophagy via activating the liver kinase B1/adenosine monophosphate-activated protein kinase (AMPK)/mTOR pathway (<xref rid="b29-mmr-0-0-12273" ref-type="bibr">29</xref>). Additionally, studies have demonstrated that Sirt3 protects against cellar damage via AMPK-mediated autophagy (<xref rid="b11-mmr-0-0-12273" ref-type="bibr">11</xref>,<xref rid="b30-mmr-0-0-12273" ref-type="bibr">30</xref>). The present study demonstrated that Sirt3 promoted the autophagy of HK-2 cells via the inhibition of Notch-1/Hes-1 signaling.</p>
<p>It is well-known that the Notch pathway is an evolutionarily conserved intercellular signaling pathway, and is involved in the course of renal development by regulating the differentiation and maturation of podocytes (<xref rid="b31-mmr-0-0-12273" ref-type="bibr">31</xref>,<xref rid="b32-mmr-0-0-12273" ref-type="bibr">32</xref>). A previous study demonstrated that autophagy in podocytes was markedly diminished when Notch signaling was upregulated (<xref rid="b33-mmr-0-0-12273" ref-type="bibr">33</xref>). However, studies on the association between the Notch pathway and autophagy in renal tubular epithelial cells are limited. In the present study, it was found that the Notch-1/Hes-1 pathway was activated in HG-stimulated HK-2cells. The promoting effects of Sirt3 on autophagy were attenuated following the activation of the Notch-1/Hes-1 pathway. This provides further evidence that Sirt3 activated autophagy in HK-2 cells via the inhibition of Notch-1/Hes-1 pathway.</p>
<p>The findings presented herein are preliminary and thus, further in-depth investigations are warranted. In future experiments, the formation of autophagosomes should be traced using the autophagic flux indicator RFP-GFP-LC3 under fluorescence microscopy. Additionally, the formation of autophagosomes in different stages of integration should be confirmed by electron microscopy. Moreover, detecting changes in LC3-II and Beclin-1 levels alone does not appear sufficient for the evaluation of autophagic activity. The induction of autophagy and the accumulation of autophagosomes are not entirely representative of the activation of the autophagic pathway. For an improved evaluation of autophagic activity, more effective methods (e.g. electron microscopy and LC3-GFP imaging) should be used for detection of the degradation process.</p>
<p>In conclusion, the present study demonstrated that the overexpression of Sirt3 induced an increase in the levels of autophagy regulators in HK-2 cells stimulated with HG. Sirt3 activated autophagy at least partly, via the inhibition of the Notch-1/Hes-1 pathway. Thus, Sirt3 may be a viable target in the treatment of DN via the inhibition of Notch-1/Hes-1 signaling.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec>
<title>Funding</title>
<p>This study was supported by the Natural Science Fund of Inner Mongolia Autonomous Region (grant no. 2019MS08064).</p>
</sec>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>YW, JC and YL conceived and designed the present study. YW and ZW were responsible for data analysis and performed the experiments. YW, JC and YL wrote the manuscript. YL reviewed and edited the manuscript. YW and YL confirm the authenticity of all the raw data. All authors read and approved the final manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-mmr-0-0-12273"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>AM</given-names></name><name><surname>Knudsen</surname><given-names>ST</given-names></name><name><surname>Cooper</surname><given-names>ME</given-names></name></person-group><article-title>Diabetic nephropathy: An insight into molecular mechanisms and emerging therapies</article-title><source>Expert Opin Ther Targets</source><volume>23</volume><fpage>579</fpage><lpage>591</lpage><year>2019</year><pub-id pub-id-type="doi">10.1080/14728222.2019.1624721</pub-id><pub-id pub-id-type="pmid">31154867</pub-id></element-citation></ref>
<ref id="b2-mmr-0-0-12273"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbertson</surname><given-names>DT</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Xue</surname><given-names>JL</given-names></name><name><surname>Louis</surname><given-names>TA</given-names></name><name><surname>Solid</surname><given-names>CA</given-names></name><name><surname>Ebben</surname><given-names>JP</given-names></name><name><surname>Collins</surname><given-names>AJ</given-names></name></person-group><article-title>Projecting the number of patients with end-stage renal disease in the United States to the year 2015</article-title><source>J Am Soc Nephrol</source><volume>16</volume><fpage>3736</fpage><lpage>3741</lpage><year>2005</year><pub-id pub-id-type="doi">10.1681/ASN.2005010112</pub-id><pub-id pub-id-type="pmid">16267160</pub-id></element-citation></ref>
<ref id="b3-mmr-0-0-12273"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Livingston</surname><given-names>MJ</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name></person-group><article-title>Autophagy in kidney homeostasis and disease</article-title><source>Nat Rev Nephrol</source><volume>16</volume><fpage>489</fpage><lpage>508</lpage><year>2020</year><pub-id pub-id-type="doi">10.1038/s41581-020-0309-2</pub-id><pub-id pub-id-type="pmid">32704047</pub-id></element-citation></ref>
<ref id="b4-mmr-0-0-12273"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Small</surname><given-names>DM</given-names></name><name><surname>Bennett</surname><given-names>NC</given-names></name><name><surname>Coombes</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>DW</given-names></name><name><surname>Gobe</surname><given-names>GC</given-names></name></person-group><article-title>Mitochondrial homeostasis is impeded by degradation and autophagy in oxidative stress-induced renal cell injury</article-title><source>Revista Espa&#x00F1;ola De Reumatismo Y Enfermedades Osteoarticulares</source><volume>11</volume><fpage>67</fpage><lpage>73</lpage><year>2013</year></element-citation></ref>
<ref id="b5-mmr-0-0-12273"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitada</surname><given-names>M</given-names></name><name><surname>Ogura</surname><given-names>Y</given-names></name><name><surname>Monno</surname><given-names>I</given-names></name><name><surname>Koya</surname><given-names>D</given-names></name></person-group><article-title>Regulating autophagy as a therapeutic target for diabetic nephropathy</article-title><source>Curr Diab Rep</source><volume>17</volume><fpage>53</fpage><year>2017</year><pub-id pub-id-type="doi">10.1007/s11892-017-0879-y</pub-id><pub-id pub-id-type="pmid">28593583</pub-id></element-citation></ref>
<ref id="b6-mmr-0-0-12273"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>SY</given-names></name><name><surname>Yao</surname><given-names>RQ</given-names></name><name><surname>Li</surname><given-names>YX</given-names></name><name><surname>Zhao</surname><given-names>PY</given-names></name><name><surname>Ren</surname><given-names>C</given-names></name><name><surname>Du</surname><given-names>XH</given-names></name><name><surname>Yao</surname><given-names>YM</given-names></name></person-group><article-title>Lysosomal quality control of cell fate: A novel therapeutic target for human diseases</article-title><source>Cell Death Dis</source><volume>11</volume><fpage>817</fpage><year>2020</year><pub-id pub-id-type="doi">10.1038/s41419-020-03032-5</pub-id><pub-id pub-id-type="pmid">32999282</pub-id></element-citation></ref>
<ref id="b7-mmr-0-0-12273"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>HJ</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Lou</surname><given-names>W</given-names></name><name><surname>Xia</surname><given-names>C</given-names></name><name><surname>Han</surname><given-names>XT</given-names></name><name><surname>Huang</surname><given-names>WJ</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>WJ</given-names></name></person-group><article-title>Accelerated kidney aging in diabetes mellitus</article-title><source>Oxid Med Cell Longev</source><volume>2020</volume><fpage>1234059</fpage><year>2020</year><pub-id pub-id-type="doi">10.1155/2020/1234059</pub-id><pub-id pub-id-type="pmid">32774664</pub-id></element-citation></ref>
<ref id="b8-mmr-0-0-12273"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>IH</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Mostoslavsky</surname><given-names>R</given-names></name><name><surname>Lombard</surname><given-names>DB</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Bruns</surname><given-names>NE</given-names></name><name><surname>Tsokos</surname><given-names>M</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name><name><surname>Finkel</surname><given-names>T</given-names></name></person-group><article-title>A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy</article-title><source>Proc Natl Acad Sci USA</source><volume>105</volume><fpage>3374</fpage><lpage>3379</lpage><year>2008</year><pub-id pub-id-type="doi">10.1073/pnas.0712145105</pub-id><pub-id pub-id-type="pmid">18296641</pub-id></element-citation></ref>
<ref id="b9-mmr-0-0-12273"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Xin</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name></person-group><article-title>Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy</article-title><source>Redox Biol</source><volume>18</volume><fpage>229</fpage><lpage>243</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.redox.2018.07.011</pub-id><pub-id pub-id-type="pmid">30056271</pub-id></element-citation></ref>
<ref id="b10-mmr-0-0-12273"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>S</given-names></name><name><surname>Tong</surname><given-names>Q</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name></person-group><article-title>SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity</article-title><source>Cell Death Differ</source><volume>27</volume><fpage>329</fpage><lpage>344</lpage><year>2020</year><pub-id pub-id-type="doi">10.1038/s41418-019-0356-z</pub-id><pub-id pub-id-type="pmid">31160717</pub-id></element-citation></ref>
<ref id="b11-mmr-0-0-12273"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>Sui</surname><given-names>M</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>L</given-names></name></person-group><article-title>SIRT3 protects against acute kidney injury via AMPK/mTOR-regulated autophagy</article-title><source>Front Physiol</source><volume>9</volume><fpage>1526</fpage><year>2018</year><pub-id pub-id-type="doi">10.3389/fphys.2018.01526</pub-id><pub-id pub-id-type="pmid">30487750</pub-id></element-citation></ref>
<ref id="b12-mmr-0-0-12273"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitada</surname><given-names>M</given-names></name><name><surname>Kume</surname><given-names>S</given-names></name><name><surname>Takeda-Watanabe</surname><given-names>A</given-names></name><name><surname>Kanasaki</surname><given-names>K</given-names></name><name><surname>Koya</surname><given-names>D</given-names></name></person-group><article-title>Sirtuins and renal diseases: Relationship with aging and diabetic nephropathy</article-title><source>Clin Sci (Lond)</source><volume>124</volume><fpage>153</fpage><lpage>164</lpage><year>2013</year><pub-id pub-id-type="doi">10.1042/CS20120190</pub-id><pub-id pub-id-type="pmid">23075334</pub-id></element-citation></ref>
<ref id="b13-mmr-0-0-12273"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Gao</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Qiu</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Ji</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><article-title>Sirt3 deficiency exacerbates diabetic cardiac dysfunction: Role of Foxo3A-Parkin-mediated mitophagy</article-title><source>Biochim Biophys Acta Mol Basis Dis</source><volume>1863</volume><fpage>1973</fpage><lpage>1983</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.bbadis.2016.10.021</pub-id><pub-id pub-id-type="pmid">27794418</pub-id></element-citation></ref>
<ref id="b14-mmr-0-0-12273"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Si</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name></person-group><article-title>Mesenchymal stem cells attenuate diabetic lung fibrosis via adjusting Sirt3-mediated stress responses in rats</article-title><source>Oxid Med Cell Longev</source><volume>2020</volume><fpage>8076105</fpage><year>2020</year><pub-id pub-id-type="pmid">32089781</pub-id></element-citation></ref>
<ref id="b15-mmr-0-0-12273"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artavanis-Tsakonas</surname><given-names>S</given-names></name><name><surname>Rand</surname><given-names>MD</given-names></name><name><surname>Lake</surname><given-names>RJ</given-names></name></person-group><article-title>Notch signaling: Cell fate control and signal integration in development</article-title><source>Science</source><volume>284</volume><fpage>770</fpage><lpage>776</lpage><year>1999</year><pub-id pub-id-type="doi">10.1126/science.284.5415.770</pub-id><pub-id pub-id-type="pmid">10221902</pub-id></element-citation></ref>
<ref id="b16-mmr-0-0-12273"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuri</surname><given-names>S</given-names></name><name><surname>Nishikawa</surname><given-names>M</given-names></name><name><surname>Yanagawa</surname><given-names>N</given-names></name><name><surname>Jo</surname><given-names>OD</given-names></name><name><surname>Yanagawa</surname><given-names>N</given-names></name></person-group><article-title>Maintenance of mouse nephron progenitor cells in aggregates with Gamma-secretase inhibitor</article-title><source>PLoS One</source><volume>10</volume><fpage>e0129242</fpage><year>2015</year><pub-id pub-id-type="doi">10.1371/journal.pone.0129242</pub-id><pub-id pub-id-type="pmid">26075891</pub-id></element-citation></ref>
<ref id="b17-mmr-0-0-12273"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Chi</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>N</given-names></name><name><surname>Zhao</surname><given-names>K</given-names></name></person-group><article-title>Pyridoxamine treatment of HK-2 human proximal tubular epithelial cells reduces oxidative stress and the inhibition of autophagy induced by high glucose levels</article-title><source>Med Sci Monit</source><volume>25</volume><fpage>1480</fpage><lpage>1488</lpage><year>2019</year><pub-id pub-id-type="doi">10.12659/MSM.914799</pub-id><pub-id pub-id-type="pmid">30799433</pub-id></element-citation></ref>
<ref id="b18-mmr-0-0-12273"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiao</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Chi</surname><given-names>Y</given-names></name></person-group><article-title>Role of Sirtuin3 in high glucose-induced apoptosis in renal tubular epithelial cells</article-title><source>Biochem Biophys Res Commun</source><volume>480</volume><fpage>387</fpage><lpage>393</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2016.10.060</pub-id><pub-id pub-id-type="pmid">27773814</pub-id></element-citation></ref>
<ref id="b19-mmr-0-0-12273"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>K</given-names></name><name><surname>Chi</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name></person-group><article-title>Pyrroloquinoline quinine protects HK-2cells against high glucose-induced oxidative stress and apoptosis through Sirt3 and PI3K/Akt/FoxO3a signaling pathway</article-title><source>Biochem Biophys Res Commun</source><volume>508</volume><fpage>398</fpage><lpage>404</lpage><year>2019</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2019.04.001</pub-id><pub-id pub-id-type="pmid">30502093</pub-id></element-citation></ref>
<ref id="b20-mmr-0-0-12273"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method</article-title><source>Methods</source><volume>25</volume><fpage>402</fpage><lpage>408</lpage><year>2001</year><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id><pub-id pub-id-type="pmid">11846609</pub-id></element-citation></ref>
<ref id="b21-mmr-0-0-12273"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizushima</surname><given-names>N</given-names></name><name><surname>Levine</surname><given-names>B</given-names></name></person-group><article-title>Autophagy in human diseases</article-title><source>N Engl J Med</source><volume>383</volume><fpage>1564</fpage><lpage>1576</lpage><year>2020</year><pub-id pub-id-type="doi">10.1056/NEJMra2022774</pub-id><pub-id pub-id-type="pmid">33053285</pub-id></element-citation></ref>
<ref id="b22-mmr-0-0-12273"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>P</given-names></name><name><surname>Mizushima</surname><given-names>N</given-names></name></person-group><article-title>Autophagy and human diseases</article-title><source>Cell Res</source><volume>24</volume><fpage>69</fpage><lpage>79</lpage><year>2014</year><pub-id pub-id-type="doi">10.1038/cr.2013.161</pub-id><pub-id pub-id-type="pmid">24323045</pub-id></element-citation></ref>
<ref id="b23-mmr-0-0-12273"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Lee</surname><given-names>MS</given-names></name></person-group><article-title>Autophagy-a key player in cellular and body metabolism</article-title><source>Nat Rev Endocrinol</source><volume>10</volume><fpage>322</fpage><lpage>337</lpage><year>2014</year><pub-id pub-id-type="doi">10.1038/nrendo.2014.35</pub-id><pub-id pub-id-type="pmid">24663220</pub-id></element-citation></ref>
<ref id="b24-mmr-0-0-12273"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Choi</surname><given-names>ME</given-names></name></person-group><article-title>Autophagy in diabetic nephropathy</article-title><source>J Endocrinol</source><volume>224</volume><fpage>R15</fpage><lpage>R30</lpage><year>2015</year><pub-id pub-id-type="doi">10.1530/JOE-14-0437</pub-id><pub-id pub-id-type="pmid">25349246</pub-id></element-citation></ref>
<ref id="b25-mmr-0-0-12273"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>WJ</given-names></name><name><surname>Huang</surname><given-names>WF</given-names></name><name><surname>Ye</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>RH</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>HL</given-names></name><name><surname>Pan</surname><given-names>QJ</given-names></name><name><surname>Liu</surname><given-names>HF</given-names></name></person-group><article-title>The activity and role of autophagy in the pathogenesis of diabetic nephropathy</article-title><source>Eur Rev Med Pharmacol Sci</source><volume>22</volume><fpage>3182</fpage><lpage>3189</lpage><year>2018</year><pub-id pub-id-type="pmid">29863264</pub-id></element-citation></ref>
<ref id="b26-mmr-0-0-12273"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>F</given-names></name></person-group><article-title>Autophagy in renal tubular injury and repair</article-title><source>Acta Physiol (Oxf)</source><volume>220</volume><fpage>229</fpage><lpage>237</lpage><year>2017</year><pub-id pub-id-type="doi">10.1111/apha.12852</pub-id><pub-id pub-id-type="pmid">28112877</pub-id></element-citation></ref>
<ref id="b27-mmr-0-0-12273"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>F</given-names></name><name><surname>Tang</surname><given-names>BL</given-names></name></person-group><article-title>Sirtuins&#x0027; modulation of autophagy</article-title><source>J Cell Physiol</source><volume>228</volume><fpage>2262</fpage><lpage>2270</lpage><year>2013</year><pub-id pub-id-type="doi">10.1002/jcp.24399</pub-id><pub-id pub-id-type="pmid">23696314</pub-id></element-citation></ref>
<ref id="b28-mmr-0-0-12273"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Shi</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Fang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Ming</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sirt3 suppresses calcium oxalate-induced renal tubular epithelial cell injury via modification of FoxO3a-mediated autophagy</article-title><source>Cell Death Dis</source><volume>10</volume><fpage>34</fpage><year>2019</year><pub-id pub-id-type="doi">10.1038/s41419-018-1169-6</pub-id><pub-id pub-id-type="pmid">30674870</pub-id></element-citation></ref>
<ref id="b29-mmr-0-0-12273"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Deng</surname><given-names>YN</given-names></name><name><surname>Zhang</surname><given-names>JY</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>YB</given-names></name><name><surname>Su</surname><given-names>H</given-names></name><name><surname>Qu</surname><given-names>QM</given-names></name></person-group><article-title>SIRT3 protects Rotenone-induced injury in SH-SY5Y cells by promoting autophagy through the LKB1-AMPK-mTOR Pathway</article-title><source>Aging Dis</source><volume>9</volume><fpage>273</fpage><lpage>286</lpage><year>2018</year><pub-id pub-id-type="doi">10.14336/AD.2017.0517</pub-id><pub-id pub-id-type="pmid">29896416</pub-id></element-citation></ref>
<ref id="b30-mmr-0-0-12273"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>K</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Liang</surname><given-names>W</given-names></name><name><surname>Que</surname><given-names>H</given-names></name></person-group><article-title>Sirt3 overexpression alleviates hyperglycemia-induced vascular inflammation through regulating redox balance, cell survival, and AMPK-mediated mitochondrial homeostasis</article-title><source>J Recept Signal Transduct Res</source><volume>39</volume><fpage>341</fpage><lpage>349</lpage><year>2019</year><pub-id pub-id-type="doi">10.1080/10799893.2019.1684521</pub-id><pub-id pub-id-type="pmid">31680596</pub-id></element-citation></ref>
<ref id="b31-mmr-0-0-12273"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surendran</surname><given-names>K</given-names></name><name><surname>Boyle</surname><given-names>S</given-names></name><name><surname>Barak</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Stomberski</surname><given-names>C</given-names></name><name><surname>McCright</surname><given-names>B</given-names></name><name><surname>Kopan</surname><given-names>R</given-names></name></person-group><article-title>The contribution of Notch1 to nephron segmentation in the developing kidney is revealed in a sensitized Notch2 background and can be augmented by reducing Mint dosage</article-title><source>Dev Biol</source><volume>337</volume><fpage>386</fpage><lpage>395</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.ydbio.2009.11.017</pub-id><pub-id pub-id-type="pmid">19914235</pub-id></element-citation></ref>
<ref id="b32-mmr-0-0-12273"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vooijs</surname><given-names>M</given-names></name><name><surname>Ong</surname><given-names>CT</given-names></name><name><surname>Hadland</surname><given-names>B</given-names></name><name><surname>Huppert</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Korving</surname><given-names>J</given-names></name><name><surname>van den Born</surname><given-names>M</given-names></name><name><surname>Stappenbeck</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Kopan</surname><given-names>R</given-names></name></person-group><article-title>Mapping the consequence of Notch1 proteolysis in vivo with NIP-CRE</article-title><source>Development</source><volume>134</volume><fpage>535</fpage><lpage>544</lpage><year>2007</year><pub-id pub-id-type="doi">10.1242/dev.02733</pub-id><pub-id pub-id-type="pmid">17215306</pub-id></element-citation></ref>
<ref id="b33-mmr-0-0-12273"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Tao</surname><given-names>M</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Jin</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>Q</given-names></name></person-group><article-title>p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway</article-title><source>Histol Histopathol</source><volume>35</volume><fpage>405</fpage><lpage>415</lpage><year>2020</year><pub-id pub-id-type="pmid">31650524</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-0-0-12273" position="float">
<label>Figure 1.</label>
<caption><p>HG reduces the viability of HK-2 cells. Values are presented as the mean &#x00B1; SD. &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01 vs. HG; <sup>#</sup>P&#x003C;0.05 and <sup>##</sup>P&#x003C;0.01 vs. HG at 0 h; <sup>&#x2736;</sup>P&#x003C;0.05 and <sup>&#x2736;&#x2736;</sup>P&#x003C;0.01 vs. NG &#x002B; M at 0 h; <sup>&#x0026;</sup>P&#x003C;0.05 and <sup>&#x0026;&#x0026;</sup>P&#x003C;0.01 vs. HG at 12 h. NG, normal glucose (5.5 mM glucose); M, mannitol (5.5 mM glucose &#x002B; 24.5 mmol/l mannitol); HG, high glucose (30 mM glucose).</p></caption>
<graphic xlink:href="mmr-24-03-12273-g00.tif"/>
</fig>
<fig id="f2-mmr-0-0-12273" position="float">
<label>Figure 2.</label>
<caption><p>Long-term culture of HK-2 cells in HG inhibits expression of Sirt3 and autophagy. (A) Representative western blots of proteins examined. Expression levels of (B) Sirt3, (D) LC-3II, (F) Beclin-1 and (H) p62 were determined by western blotting. &#x03B2;-actin was used as an internal control. mRNA expression levels of (C) Sirt3, (E) LC-3II, (G) Beclin-1 and (I) p62 were determined by reverse transcription-quantitative PCR. (J) Effects of HG on the expression of Sirt3 were determined by immunofluorescence staining [scale bar, 50 &#x00B5;m; the enlarged image is a larger scale image of the area in the merged image represented by the white box (scale bar, 25 &#x00B5;m)]. Sirt3 (green) was defined by staining cells with anti-Sirt3 antibody. DAPI staining (blue) was used to determine the position of the nucleus. <sup>#</sup>P&#x003C;0.05 and <sup>##</sup>P&#x003C;0.01 vs. NG; &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01 vs. HG at 12 h. NG, normal glucose (5.5 mM glucose); M, mannitol (5.5 mM glucose &#x002B; 24.5 mmol/l mannitol); HG, high glucose (30 mM glucose); Sirt3, sirtuin3.</p></caption>
<graphic xlink:href="mmr-24-03-12273-g01.tif"/>
</fig>
<fig id="f3-mmr-0-0-12273" position="float">
<label>Figure 3.</label>
<caption><p>Long-term culture of HK-2 cells in HG activates Notch-1/Hes-1 signaling. (A) Representative western blots of proteins examined. Expression of (B and C) Notch-1 and (D and E) Hes-1 was determined by western blotting and reverse transcription-quantitative PCR. &#x03B2;-actin was used as an internal control. <sup>#</sup>P&#x003C;0.05 and <sup>##</sup>P&#x003C;0.01 vs. NG; &#x002A;&#x002A;P&#x003C;0.01 vs. HG at 12 h. NG, normal glucose (5.5 mM glucose); M, mannitol (5.5 mM glucose &#x002B; 24.5 mmol/l mannitol); HG, high glucose (30 mM glucose); Notch-1, notch homolog 1; Hes-1, hairy and enhancer of split-1.</p></caption>
<graphic xlink:href="mmr-24-03-12273-g02.tif"/>
</fig>
<fig id="f4-mmr-0-0-12273" position="float">
<label>Figure 4.</label>
<caption><p>Sirt3 activates autophagy in HG-stimulated HK-2 cells. (A) Western blot analysis and (B) RT-qPCR were used to detect the transfection efficiency of the overexpression plasmid in HK-2 cells. <sup>&#x0026;&#x0026;</sup>P&#x003C;0.01 vs. control-vector. (C) Effect of Sirt3 on cell viability. &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01 vs. HG; <sup>#</sup>P&#x003C;0.05 and <sup>##</sup>P&#x003C;0.01 vs. HG at 0 h; <sup>&#x2736;</sup>P&#x003C;0.05 and <sup>&#x2736;&#x2736;</sup>P&#x003C;0.01 vs. NG; <sup>&#x0026;</sup>P&#x003C;0.05 and <sup>&#x0026;&#x0026;</sup>P&#x003C;0.01 vs. HG at 12 h. (D) Representative western blots of proteins examined. Expression levels of (E and F) LC-3II, (G and H) Beclin-1, (I and J) p62 and (K and L) Sirt3 were determined by western blot analysis and RT-qPCR. &#x03B2;-actin was used as an internal control. <sup>##</sup>P&#x003C;0.01 vs. NG; &#x002A;&#x002A;P&#x003C;0.01 vs. HG. NG, normal glucose (5.5 mM glucose); HG, high glucose (30 mM glucose); RT-qPCR, reverse transcription-quantitative PCR; Sirt3, sirtuin3.</p></caption>
<graphic xlink:href="mmr-24-03-12273-g03.tif"/>
</fig>
<fig id="f5-mmr-0-0-12273" position="float">
<label>Figure 5.</label>
<caption><p>Sirt3 inhibits the activation of the Notch-1/Hes-1 pathway in HG-stimulated HK-2 cells. (A) Representative western blots of proteins examined. Expression of (B and C) Notch-1 and (D and E) Hes-1 were determined by western blot analysis and reverse transcription-quantitative PCR. &#x03B2;-actin was used as an internal control. <sup>##</sup>P&#x003C;0.01 vs. NG; &#x002A;&#x002A;P&#x003C;0.01 vs. HG. NG, normal glucose (5.5 mM glucose); HG, high glucose (30 mM glucose); Sirt3, sirtuin3; Notch-1, notch homolog 1; Hes-1, hairy and enhancer of split-1.</p></caption>
<graphic xlink:href="mmr-24-03-12273-g04.tif"/>
</fig>
<fig id="f6-mmr-0-0-12273" position="float">
<label>Figure 6.</label>
<caption><p>Sirt3 promotes the autophagy of HK-2 cells via the inhibition of Notch-1/Hes-1 signaling. (A-C) Effects of Notch-1/Hes-1 pathway activator (Jagged-1) on Notch-1 expression in HG-stimulated HK-2 cells. (D-E) Effects of Jagged-1 on Hes-1 expression in HG-stimulated HK-2 cells. (F) Representative western blots of LC-3II, Beclin-1 and p62 proteins. Expression levels of (G and H) LC-3II, (I and J) Beclin-1 and (K and L) p62 were determined by western blot analysis and reverse transcription-quantitative PCR. &#x03B2;-actin was used as an internal control. <sup>#</sup>P&#x003C;0.05 and <sup>##</sup>P&#x003C;0.01 vs. NG; &#x002A;P&#x003C;0.05 and &#x002A;&#x002A;P&#x003C;0.01 vs. HG &#x002B; pCMV-Sirt3 group. NG, normal glucose (5.5 mM glucose); HG, high glucose (30 mM glucose); Sirt3, sirtuin3; Notch-1, notch homolog 1; Hes-1, hairy and enhancer of split-1.</p></caption>
<graphic xlink:href="mmr-24-03-12273-g05.tif"/>
</fig>
</floats-group>
</article>
